TREM-1 targeting compounds (Novo Nordisk)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameTREM-1 targeting compounds (Novo Nordisk)
Drug Alias Nameseptic shock therapy (BioXell)TREM-1 targeting compounds (BioXell)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTriggering receptor expressed on myeloid cells 1 inhibitors
TargetsTriggering receptor expressed on myeloid cells 1
Therapy Area/IndicationsShock, Septic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItalyDenmark
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioxell SPA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioxell SPANovo Nordisk A/SMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsShock, Septic

Other Information

ATC CodeN/A
Related LinksN/A